Appointment booking for Dr. Timothy Mcclain, MD is currently not available.Dr. Timothy Mcclain, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Timothy Mcclain, MD (he/him) is a Internist in Laurel, MD with over 19 years of experience. What is your opinion of Dr. Timothy Mcclain, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 19 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Timothy Mcclain, MD has received over $4,485 which includes payments from the following companies:
$1,031.60 from Novo Nordisk Inc
$771.36 from AstraZeneca Pharmaceuticals LP
$473.42 from GlaxoSmithKline, LLC.
$393.21 from LILLY USA, LLC
$357.16 from Amgen Inc.
$244.71 from Merck Sharp & Dohme Corporation
$211.56 from Boehringer Ingelheim Pharmaceuticals, Inc.
$132.73 from sanofi-aventis U.S. LLC
$95.55 from Horizon Pharma plc
$89.93 from Arbor Pharmaceuticals, Inc.
$87.05 from Amarin Pharma Inc.
$81.32 from Janssen Pharmaceuticals, Inc
$69.31 from Eisai Inc.
$64.95 from Daiichi Sankyo Inc.
$64.64 from Pfizer Inc.
$38.91 from West-Ward Pharmaceuticals
$35.31 from Baxter Healthcare
$34.07 from Allergan Inc.
$34.06 from Phadia US Inc.
$23.60 from AbbVie, Inc.
Payments received by Dr. Timothy Mcclain, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!